TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20086317

Group type: EXPERIMENTAL
Intervention: Broccoli with mayonnaise (MS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Broccoli with oil (OIL)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Broccoli (CON)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Incremental areas under the curves (IAUCs) after MS meal
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Incremental areas under the curves (IAUCs) after OIL meal
Number of subjects: 18
Study: 16498057

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg daily for 12 weeks)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 99
Study: 15487957

Group type: EXPERIMENTAL
Intervention: Electoral Roll (ER) arm
Number of subjects: 881

Group type: COMPARATOR
Intervention: General Practice (GP) arm
Number of subjects: 881

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 881
Study: 10890310

Group type: EXPERIMENTAL
Intervention: Balanced mixture of amino acids (B)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Devoid of tryptophan (T‐)
Number of subjects: 12
Study: 9179454

Group type: EXPERIMENTAL
Intervention: Progesterone-releasing vaginal ring
Number of subjects: 1536

Group type: COMPARATOR
Intervention: Copper T 380A IUD
Number of subjects: 1536

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 1536
Study: 8299662

Group type: EXPERIMENTAL
Intervention: CL284,846 (20 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3670870

Group type: EXPERIMENTAL
Intervention: Short-form McGill Pain Questionnaire (SF-MPQ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard McGill Pain Questionnaire (MPQ)
Number of subjects: 0
Study: 28990122

Group type: EXPERIMENTAL
Intervention: fluoridated toothpaste + flossing + infiltration
Number of subjects: 50

Group type: COMPARATOR
Intervention: fluoridated toothpaste + flossing
Number of subjects: 50
Study: 27881122

Group type: EXPERIMENTAL
Intervention: WeChat health education intervention (50 malaria prevention and treatment messages)
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Control group (50 health news messages)
Number of subjects: 1441

Group type: EXPERIMENTAL
Intervention: WeChat health education intervention
Number of subjects: 1441
Study: 24980392

Group type: EXPERIMENTAL
Intervention: DX-2930 (0.1 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: DX-2930 (0.3 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: DX-2930 (1.0 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: DX-2930 (3.0 mg/kg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 22916489

Group type: EXPERIMENTAL
Intervention: Neotype medical drainage bag
Number of subjects: 206
Study: 20525230

Group type: EXPERIMENTAL
Intervention: Twice the recommended dietary allowance of 14 micronutrients for 6 months
Number of subjects: 847

Group type: COMPARATOR
Intervention: Standard recommended dietary allowance of six multivitamins for 6 months
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Twice the recommended dietary allowance of 14 micronutrients in ART stratum
Number of subjects: 847

Group type: COMPARATOR
Intervention: Standard recommended dietary allowance of six multivitamins in ART stratum
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Twice the recommended dietary allowance of 14 micronutrients in non-ART stratum
Number of subjects: 847

Group type: COMPARATOR
Intervention: Standard recommended dietary allowance of six multivitamins in non-ART stratum
Number of subjects: 847

Group type: EXPERIMENTAL
Intervention: Twice the recommended dietary allowance of 14 micronutrients
Number of subjects: 847

Group type: COMPARATOR
Intervention: Standard recommended dietary allowance of six multivitamins
Number of subjects: 847
Study: 18272319

Group type: EXPERIMENTAL
Intervention: Ketalar (ketamine) administered at induction until the end of surgery
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo (physiologic serum) administered in the same condition
Number of subjects: 208
Study: 16021001

Group type: EXPERIMENTAL
Intervention: No. 7 lens
Number of subjects: 24

Group type: COMPARATOR
Intervention: BE lens
Number of subjects: 24
Study: 12598279

Group type: EXPERIMENTAL
Intervention: Pressure application on the extra 1 point for 10 min
Number of subjects: 25

Group type: COMPARATOR
Intervention: Pressure application on the control point for 5 min
Number of subjects: 25
Study: 9884380

Group type: EXPERIMENTAL
Intervention: Dobutamine for 72 hours
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no dobutamine)
Number of subjects: 9
Study: 8613275

Group type: EXPERIMENTAL
Intervention: Follicular phase (days 7 to 10 after menses)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Luteal phase (days 7 to 10 after the leutenizing hormone surge)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Stress response
Number of subjects: 33
Study: 1830266

Group type: EXPERIMENTAL
Intervention: Ethynylestradiol (30 micrograms) alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ethynylestradiol (30 micrograms) with gestodene (75 micrograms)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ethynylestradiol (30 micrograms) with desogestrel (150 micrograms)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: All doses of EE2
Number of subjects: 10
Study: 6124671

Group type: EXPERIMENTAL
Intervention: 1 g methylprednisolone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1 g methylprednisolone (after placebo)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 20
Study: 29356438

Group type: EXPERIMENTAL
Intervention: Tobacco use
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Alcohol use
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Cannabis use
Number of subjects: 404
Study: 29351770

Group type: EXPERIMENTAL
Intervention: Habitual functional training during short term stays at nursing homes
Number of subjects: 8
Study: 25405657

Group type: EXPERIMENTAL
Intervention: Yukon Choice PC
Number of subjects: 2603

Group type: COMPARATOR
Intervention: XIENCE
Number of subjects: 2603

Group type: COMPARATOR
Intervention: CYPHER
Number of subjects: 2603
Study: 25083133

Group type: EXPERIMENTAL
Intervention: Exercise program combined with NMES
Number of subjects: 63

Group type: COMPARATOR
Intervention: Exercise-only program
Number of subjects: 63
Study: 21984397

Group type: EXPERIMENTAL
Intervention: On-sight ascent (lead climb or top-rope)
Number of subjects: 19
Study: 19786940

Group type: EXPERIMENTAL
Intervention: Half-dose reteplase (r-PA) plus abciximab
Number of subjects: 38

Group type: COMPARATOR
Intervention: Full-dose r-PA
Number of subjects: 38
Study: 17270340

Group type: EXPERIMENTAL
Intervention: Tamoxifen 1 mg
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Tamoxifen 2.5 mg
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Tamoxifen 5 mg
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study: 15039508

Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy 1 hour per week for 12 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Supportive therapy (control group)
Number of subjects: 28
Study: 11727074

Group type: EXPERIMENTAL
Intervention: MIST VR (virtual reality simulator)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Laparoscopic Z maze-tracking task
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Laparoscopic U maze-tracking task
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 32
Study: 10087431

Group type: EXPERIMENTAL
Intervention: Early introduction of fluindione (20 mg once daily starting on day 1)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Delayed introduction of fluindione (20 mg once daily starting on day 10)
Number of subjects: 223
Study: 7820043

Group type: EXPERIMENTAL
Intervention: 2-chlorodeoxyadenosine (2-CdA)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: 2-chlorodeoxyadenosine (2-CdA) in patients resistant or intolerant to 2'-deoxycoformycin
Number of subjects: 144

Group type: COMPARATOR
Intervention: pentoxifylline
Number of subjects: 144
Study: 3071451

Group type: EXPERIMENTAL
Intervention: 100 mg of aceclofenac
Number of subjects: 0

Group type: COMPARATOR
Intervention: 650 mg of paracetamol
Number of subjects: 0
Study: 29914580

Group type: EXPERIMENTAL
Intervention: Strength training group
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 27672397

Group type: EXPERIMENTAL
Intervention: Brazilian propolis toothpaste
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no propolis toothpaste)
Number of subjects: 96
Study: 23652417

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA) followed by vertebroplasty
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vertebroplasty only
Number of subjects: 36
Study: 23735480

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sedentary control (book club)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Active control (gym exercise)
Number of subjects: 68
Study: 21537337

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerine treatment (1.25 mg patch for 6 months)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 45
Study: 18359309

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 14527

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 14527

Group type: EXPERIMENTAL
Intervention: Both captopril and valsartan
Number of subjects: 14527

Group type: COMPARATOR
Intervention: Control group (without dm)
Number of subjects: 14527

Group type: EXPERIMENTAL
Intervention: Overall mortality and composite cardiovascular events
Number of subjects: 14527
Study: 16894240

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (in mice)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thiazolidinediones (in vitro treatment of 3T3 F442A adipocytes)
Number of subjects: 0
Study: 12953340

Group type: COMPARATOR
Intervention: Double-strength grapefruit juice (DS GFJ) 240 mL tid for 3 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Single-strength grapefruit juice (SS GFJ) 240 mL
Number of subjects: 24

Group type: COMPARATOR
Intervention: Double-strength grapefruit juice (DS GFJ) 240 mL
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nine glasses of double-strength grapefruit juice (DS GFJ)
Number of subjects: 24
Study: 11763944

Group type: EXPERIMENTAL
Intervention: Colgate Sensitive Maximum Strength dentifrice (5.0% potassium nitrate and 0.454% stannous fluoride)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Fresh Mint Sensodyne dentifrice (5.0% potassium nitrate and 0.76% sodium monofluorophosphate)
Number of subjects: 101
Study: 8646509

Group type: EXPERIMENTAL
Intervention: Vaccinia melanoma oncolysate (VMO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo of live vaccinia vaccine virus (V)
Number of subjects: 0
Study: 1513726

Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (0.15 mg/kg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 25
Study: 6475060

Group type: EXPERIMENTAL
Intervention: Moderately high-dose methotrexate (MTX) 250 mg/m2 to 750 mg/m2 at 10-day intervals
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (MTX) 5 to 15 g at 10-day intervals
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ultra-high therapy with a cumulative dose of 205 g MTX
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Two cases of severe malignant non-Hodgkin's lymphoma treated with MTX (1 patient received 2 X 1 g MTX, the other received a single dose of 5 g MTX)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Complications from high-dose MTX therapy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-dose MTX therapy
Number of subjects: 40
Study: 31436446

Group type: EXPERIMENTAL
Intervention: Motivational strategies
Number of subjects: 352

Group type: COMPARATOR
Intervention: Empathic reflections
Number of subjects: 352

Group type: COMPARATOR
Intervention: Spoken voice
Number of subjects: 352

Group type: COMPARATOR
Intervention: Animated narrator
Number of subjects: 352
Study: 29287863

Group type: EXPERIMENTAL
Intervention: Intranasal ketamine (1.5 mg/kg)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Intranasal fentanyl (1.5 mcg/kg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Intravenous paracetamol (10 mg/kg)
Number of subjects: 63
Study: 27482002

Group type: EXPERIMENTAL
Intervention: High-dose omega-3 fatty acids
Number of subjects: 358

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 358
Study: 24612095

Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bevacizumab injections
Number of subjects: 60
Study: 23019837

Group type: EXPERIMENTAL
Intervention: Oral Midazolam (0.5 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oral Diazepam (0.5 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intravenous Midazolam (0.06 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral Placebo
Number of subjects: 40
Study: 19734131

Group type: EXPERIMENTAL
Intervention: Spa therapy plus home exercises and usual medical treatment
Number of subjects: 382

Group type: COMPARATOR
Intervention: Exercises and usual treatment (Control)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Quality of life (Short Form 36)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Patient acceptable symptom state
Number of subjects: 382
Study: 17914134

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium lactate (daily dose about 800 mg calcium)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium phosphate (daily dose about 800 mg calcium)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low fat milk (daily dose about 800 mg calcium)
Number of subjects: 0
Study: 15770505

Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia (TIVA)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Balanced anesthesia (BA)
Number of subjects: 52
Study: 12475451

Group type: EXPERIMENTAL
Intervention: Endovascular cooling during primary PCI
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no endovascular cooling)
Number of subjects: 42
Study: 9802138

Group type: EXPERIMENTAL
Intervention: Tumour specimens
Number of subjects: 35

Group type: COMPARATOR
Intervention: Non-tumour specimens
Number of subjects: 35

Group type: COMPARATOR
Intervention: Non-tumour mucosa
Number of subjects: 35
Study: 7625364

Group type: EXPERIMENTAL
Intervention: Low-fat diet (30% fat, 10% saturated)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Baseline diet (37% fat, 15% saturated)
Number of subjects: 63
Study: 2506337

Group type: EXPERIMENTAL
Intervention: Alcohol (0.694 g of alcohol per kg b.wt.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 24
Study: 362900

Group type: EXPERIMENTAL
Intervention: Oral gentamicin sulfate therapy (2.5 mg/kg every six hours for one week)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Dextrose-and-water placebo
Number of subjects: 42
Study: 29894642

Group type: EXPERIMENTAL
Intervention: Reduced-fat chocolate milk (CM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sports beverage (SB)
Number of subjects: 0
Study: 27798224

Group type: EXPERIMENTAL
Intervention: Amphetamine (10 mg)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 26101142

Group type: EXPERIMENTAL
Intervention: Virgin Argan oil (VAO)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 37
Study: 23945724

Group type: EXPERIMENTAL
Intervention: New guidelines group (NGG) with counseling to continue breastfeeding, offer red meat ≥3 d/wk, and offer fruit and vegetables daily
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: New guidelines group (NGG)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 85
Study: 19948948

Group type: EXPERIMENTAL
Intervention: Trospium 60 mg extended-release once daily
Number of subjects: 24

Group type: COMPARATOR
Intervention: Trospium 20 mg immediate-release tablets twice daily
Number of subjects: 24
Study: 20071813

Group type: COMPARATOR
Intervention: 4 mg Ondansetron (Group O)
Number of subjects: 150

Group type: COMPARATOR
Intervention: 8 mg Dexamethasone (Group D)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 4 mg Ondansetron plus 8 mg Dexamethasone (Group OD)
Number of subjects: 150
Study: 17064231

Group type: EXPERIMENTAL
Intervention: Home visiting intervention for asthma self-management
Number of subjects: 0
Study: 14637327

Group type: EXPERIMENTAL
Intervention: Repeated olfactory presentations of a cheeseburger followed by apple pie as the new food stimulus.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Food reinforcement task with cheeseburger followed by apple pie.
Number of subjects: 0
Study: 11087063

Group type: EXPERIMENTAL
Intervention: Snoezelen (sensory environment)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Traditional relaxation programme
Number of subjects: 73
Study: 8831653

Group type: EXPERIMENTAL
Intervention: Relaxation technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reading group (control)
Number of subjects: 60
Study: 1346008

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 248

Group type: COMPARATOR
Intervention: No prophylaxis (Control)
Number of subjects: 248
Study: 6548392

Group type: EXPERIMENTAL
Intervention: Commercial oral elixir of theophylline
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Rectal suppository of aminophylline
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Rectal enema of theophylline monoethanolamine
Number of subjects: 6
Study: 30176671

Group type: EXPERIMENTAL
Intervention: 20 mg WP-0508ST
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 40 mg WP-0508ST
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95
Study: 29381502

Group type: EXPERIMENTAL
Intervention: Cardiac educational program
Number of subjects: 127
Study: 27482610

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 5131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5131
Study: 24939916

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention (n = 104) incorporating psychosocial and pharmacological support for 4 months postdischarge
Number of subjects: 205

Group type: COMPARATOR
Intervention: Treatment as usual control (n = 101)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention (n = 104)
Number of subjects: 205
Study: 23131890

Group type: EXPERIMENTAL
Intervention: Amisulpride 400 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aripiprazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20729233

Group type: EXPERIMENTAL
Intervention: 3-monthly 3-week treatments with oral ciprofloxacin and inhaled colistin
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo controls
Number of subjects: 65
Study: 17296994

Group type: COMPARATOR
Intervention: Normal-appearing pyramidal tract (PYT) in RRMS patients
Number of subjects: 29

Group type: COMPARATOR
Intervention: PYT lesions in RRMS patients
Number of subjects: 29

Group type: COMPARATOR
Intervention: Correlation analysis
Number of subjects: 29
Study: 16272182

Group type: EXPERIMENTAL
Intervention: eptapirone 1.5mg at 10 AM
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: eptapirone 1.5mg at 11 PM
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: buspirone 20mg at 11 PM
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 11900104

Group type: EXPERIMENTAL
Intervention: Alternating-case words and pseudowords
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pure-case words and pseudowords
Number of subjects: 0
Study: 10515037

Group type: EXPERIMENTAL
Intervention: rovamycin
Number of subjects: 249

Group type: COMPARATOR
Intervention: metronidazole
Number of subjects: 249

Group type: COMPARATOR
Intervention: tonidazol
Number of subjects: 249

Group type: COMPARATOR
Intervention: amoxicilline
Number of subjects: 249

Group type: COMPARATOR
Intervention: clarithromycin
Number of subjects: 249

Group type: COMPARATOR
Intervention: omeprazole
Number of subjects: 249

Group type: COMPARATOR
Intervention: azitromycin
Number of subjects: 249
Study: 7548709

Group type: EXPERIMENTAL
Intervention: Two-stage sequential design with variance-based weights for treatment effects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-stage crossover design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual crossover trial
Number of subjects: 0
Study: 2044499

Group type: EXPERIMENTAL
Intervention: Children's Epilepsy Program (experimental group)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 365
Study: 7011078

Group type: EXPERIMENTAL
Intervention: Cimetidine (200 mg every 6 hours)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Antacid (Maalox, 10 ml/hour)
Number of subjects: 135

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 135
Study: 31318259

Group type: EXPERIMENTAL
Intervention: Central Speaker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Communicational remembering in a looped serial transmission chain
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Central Speaker's perceived group membership (ingroup vs outgroup)
Number of subjects: 0
Study: 30526423

Group type: EXPERIMENTAL
Intervention: All-human operator configuration
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Human-autonomy teams
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Unplanned autonomy failures
Number of subjects: 3
Study: 28560524

Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass
Number of subjects: 24

Group type: COMPARATOR
Intervention: Healthy controls (normal weights and overweights)
Number of subjects: 24